Navigation Links
Nastech Appoints MDRNA, Inc. Directors Strategic Advisory Board
Date:2/5/2008

BOTHELL, Wash., Feb. 5 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. ("Nastech") (Nasdaq: NSTK) announced today that it has named members to the MDRNA, Inc. ("MDRNA") Directors Strategic Advisory Board that will provide scientific, financial and corporate governance expertise as Nastech moves to establish MDRNA, currently a wholly-owned subsidiary, as an independent company.

Advisory Board appointees include:

Susan B. Bayh, J.D. has been a director of Nastech since July 2005 as a member of the Compensation and chairman of the Nominating and Corporate Governance Committees of the Board of Directors. Mrs. Bayh currently serves on the boards of directors of Curis, Inc., a therapeutic drug development company, Dendreon Corporation, a therapeutic drug development company, Dyax Corp., a biopharmaceutical company, Emmis Communications, a diversified media company, and Wellpoint, Inc., a Blue Cross / Blue Shield company. In addition, Mrs. Bayh is a member of the Audit and Compensation Committees of the board of directors of Curis, Inc., and a member of the Compensation Committee of the board of directors of Emmis Communications. Previously, Mrs. Bayh also served on the boards of directors of Cubist Pharmaceuticals, Inc., a pharmaceutical company, from 2000 to 2004, and Esperion Therapeutics, Inc., a biopharmaceutical company, from 2000 to 2003. From 1994 to 2004, she was a Distinguished Visiting Professor at the College of Business Administration at Butler University in Indianapolis, Indiana. From 1994 to 2000, she was a Commissioner for the International Joint Commission of the Water Treaty Act between the United States and Canada. From 1989 to 1994, Mrs. Bayh served as an attorney in the Pharmaceutical Division of
'/>"/>

SOURCE Nastech Pharmaceutical Company Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics
2. Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs
3. Nastech Pharmaceutical Company Announces the Jeffrey Wenig Memorial Award for Outstanding Achievement in Drug Delivery
4. Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery
5. Milestone Scientific Appoints Dental Industry Veteran Scott Mahnken as New Director of Marketing
6. Skinvisible Appoints New Board Member
7. Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors
8. Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business
9. Crdentia Appoints Charlie Mayhone to Director of Operations for its National Travel Division and Charlotte, North Carolina Market
10. National Institutes of Health Appoints Timothy C. Birdsall, ND to CAM Advisory Council
11. CPF Appoints Mishka Michon Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014 Thousands of DePuy Pinnacle hip ... individuals who were allegedly injured by a metal-on-metal version ... forward in U.S. District Court, Northern District of Texas, ... on July 18, 2014, U.S. District Judge Ed Kinkeade ... Plaintiffs’ Steering Committee that sought the deposition of a ...
(Date:7/28/2014)... Glutamine is the most abundant single amino ... conditionally essential during times when the body undergoes large ... Immune System Support. , Having a heavy work out ... with additional glutamine may be advantageous. Glutamine supplementation may ... digestion and immune system function. Stress on the body ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Ticket Down ... Colombia tickets in Miami, FL at the Sun Life ... South American football between Argentina and Brazil has is one ... stronger worldwide, more rivalries are forming on a consistent basis. ... reached a new height in the recent 2014 World Cup. ...
(Date:7/28/2014)... 2014 (HealthDay News) --,The more chronic medical conditions people ... may be, a new study claims. Since ... issues, scientists at Johns Hopkins Bloomberg School of Public ... why gains in life expectancy are slowing in the ... as diabetes, kidney disease and heart failure is now ...
(Date:7/28/2014)... News) -- Endurance runners are far more likely to ... according to a new study. The researchers ... warm climates are actually 10 times more likely to ... common sudden death of a young and apparently healthy ... irregular heartbeat, often gets a lot more media attention. ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 4Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 2Health News:Betancourt Nutrition Introduces Glutamine Plus with Sustamine® L-Alanyl-L-Glutamine 3Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 3Health News:Chronic Medical Conditions Can Shorten Seniors' Lives: Study 2Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2
... COLUMBUS, Ohio Chronic inhalation of polluted air appears ... white blood cells, setting off events that lead to ... model. This finding narrows the gap in researchers, ... the risk for cardiovascular problems and other diseases. ...
... Jeremy M. Berg, Ph.D., director of the National ... Institutes of Health (NIH), and Norman P. Neureiter, Ph.D., ... the American Association for the Advancement of Science (AAAS), ... Service Award for their vision and leadership in science ...
... way of discovering a gene,s function is to switch it ... an organism. If a gene is essential for survival, however, ... the gene,s function can be determined. Researchers at Cold Spring ... interference (RNAi) technology to temporarily turn off any essential gene ...
... release is available in French . Montreal, ... treat tics in Tourette syndrome may be as effective as ... a new study published in a special edition of the ... Research Centre of the Louis-H. Lafontaine Hospital affiliated with Universit ...
... HealthDay Reporter , WEDNESDAY, April 13 (HealthDay News) ... in controlling and containing the spread of potentially lethal ... one study showed that certain interventions could decrease transmissions ... the other found no improvement when a somewhat different ...
... HealthDay Reporter , WEDNESDAY, April 13 (HealthDay News) -- The ... to a decade before symptoms appear, a new study finds. ... Massachusetts General Hospital in Boston did brain imaging tests on ... the 33 people in the Mass General group, eight developed ...
Cached Medicine News:Health News:Polluted air leads to disease by promoting widespread inflammation 2Health News:Polluted air leads to disease by promoting widespread inflammation 3Health News:Polluted air leads to disease by promoting widespread inflammation 4Health News:Polluted air leads to disease by promoting widespread inflammation 5Health News:American Chemical Society honors Jeremy Berg and Norman Neureiter with Public Service Award 2Health News:American Chemical Society honors Jeremy Berg and Norman Neureiter with Public Service Award 3Health News:CSHL team perfects non-lethal way of switching off essential genes in mice 2Health News:CSHL team perfects non-lethal way of switching off essential genes in mice 3Health News:Tourette Syndrome: non-drug therapy to reduce tics 2Health News:Studies Highlight Challenge of Controlling Resistant Bacteria in Hospitals 2Health News:Studies Highlight Challenge of Controlling Resistant Bacteria in Hospitals 3Health News:Brain May Shrink in Decade Before Alzheimer's Symptoms Appear 2Health News:Brain May Shrink in Decade Before Alzheimer's Symptoms Appear 3Health News:Brain May Shrink in Decade Before Alzheimer's Symptoms Appear 4
(Date:7/28/2014)... 2014  ProteinSimple announced today that it has launched ... assay allows users to detect all proteins separated in ... users can analyze proteins without the need for an ... protein analysis as we know it today. First, the Simple ... no messy gels, no transfer tanks, no blots, no ...
(Date:7/28/2014)... Germany and LONDON ... , Collaboration aims to create and commercialize ... guide the use of IRESSA  for non-small cell lung ... on QIAGEN,s FDA-approved  therascreen   EGFR test and is planned ... automated instruments  Project enabled by AstraZeneca master ...
(Date:7/28/2014)... 28, 2014 OmPrompt today ... to help it meet the global demand for ... and logistics. Albion joins Shackleton Ventures. ... Over the past 18 months OmPrompt has underpinned ... management team and its operations. The new funding ...
Breaking Medicine Technology:ProteinSimple Says "Never Run a Gel Again!" 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6OmPrompt Funded for Customer Automation Management Market Expansion 2
... GREEN BAY, Wis., Jan. 10, 2012  With increasing demands ... longer hours or shuttling the children to and from ... of a challenge. To make life simpler for shoppers ... its mobile pharmacy app, allowing users to quickly and ...
... Oramed Pharmaceuticals Inc. (OTCBB:ORMP) ( http://www.oramed.com ... today that it has filed a provisional patent application ... a combination therapy of its lead compound, ORMD-0801 in ... no such approved combination product available on the market ...
Cached Medicine Technology:Shopko Launches Mobile Pharmacy App to Maximize Customer Convenience 2Oramed Pharmaceuticals Files US Patent Application for Combination Oral Treatment of Diabetes 2Oramed Pharmaceuticals Files US Patent Application for Combination Oral Treatment of Diabetes 3
IRMA kit for detection of the cardiac marker Myoglobin...
... The assay is an immunometric ... measurement of Prolactin in human ... the sample is bound by ... different epitopes. One antibody is ...
... Immunosorbent Assay (ELISA) serves the quantitative,determination of ... serum and,urine. In a 1 hour incubation ... bound to an,available excess of polyclonal rabbit ... surface of the microtitre plates. After a ...
... method for the semi-quantitative determination of ... human serum. The results of the ... an aid in the diagnosis of ... with elevated anti-neutrophil cytoplasmic antibodies (P-ANCA) ...
Medicine Products: